Back
SAB Biotherapeutics, Inc. Stock Predictions
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now
Buy
71
SABS
SAB Biotherapeutics, Inc.
Last Price:
$3.54
Seasonality Move:
-14.12%
7 Day Trial
ALL ACCESS PASS
$
7
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist NowSAB Biotherapeutics, Inc. Stock Forecast
-
Is SAB Biotherapeutics, Inc. Stock Undervalued?The current SAB Biotherapeutics, Inc. [SABS] share price is $3.98. The Score for SABS is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
SABS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will SAB Biotherapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
SAB Biotherapeutics, Inc. Stock Rating
Data Unavailable
SAB Biotherapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sab.bio
52-Week Data
52-Week High:
6.60
52-Week Low:
1.00
Prediction Charts
Market Cap:
189.5M
Price in USD:
3.98
Volume:
505.9K
Beta:
0.59
Technical Analysis
SMA50:
3.04
SMA100:
2.65
SMA200:
2.18
52-Wk Change:
34.01%
Stock Predictions
-
Is SAB Biotherapeutics, Inc. stock public?Yes, SAB Biotherapeutics, Inc. is a publicly traded company.
-
What is the SAB Biotherapeutics, Inc. stock quote today?The SAB Biotherapeutics, Inc. stock price is 3.98 USD today.
-
How to buy SAB Biotherapeutics, Inc. stock online?You can buy SAB Biotherapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 3.24 | 3.50 | 3.50 | 3.23 |
| Nov-18 | 3.44 | 3.91 | 3.97 | 3.43 |
| Nov-19 | 3.90 | 3.83 | 4.00 | 3.71 |
| Nov-20 | 3.88 | 3.80 | 3.97 | 3.70 |
| Nov-21 | 3.85 | 3.95 | 4.00 | 3.68 |
| Nov-24 | 4.00 | 4.02 | 4.10 | 3.80 |
| Nov-25 | 4.03 | 3.93 | 4.15 | 3.89 |
| Nov-26 | 3.97 | 4.04 | 4.11 | 3.90 |
| Nov-28 | 4.08 | 3.95 | 4.19 | 3.93 |
| Dec-1 | 3.95 | 3.79 | 4.03 | 3.64 |
| Dec-2 | 3.81 | 3.64 | 3.87 | 3.61 |
| Dec-3 | 3.66 | 3.70 | 3.78 | 3.58 |
| Dec-4 | 3.70 | 3.80 | 3.92 | 3.65 |
| Dec-5 | 3.82 | 3.98 | 4.08 | 3.81 |
SAB Biotherapeutics, Inc. Earnings
Data Unavailable
SAB Biotherapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.
* SAB Biotherapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.